Victory Capital Management Inc. boosted its position in shares of Cardinal Health, Inc. (NYSE:CAH – Free Report) by 18.1% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 2,698,189 shares of the company’s stock after purchasing an additional 414,074 shares during the quarter. Victory Capital Management Inc. owned approximately 1.15% of Cardinal Health worth $554,478,000 at the end of the most recent reporting period.
Other institutional investors also recently bought and sold shares of the company. Nordea Investment Management AB boosted its position in Cardinal Health by 328.3% during the fourth quarter. Nordea Investment Management AB now owns 645,436 shares of the company’s stock worth $133,741,000 after purchasing an additional 494,731 shares in the last quarter. Procyon Advisors LLC boosted its position in Cardinal Health by 78.7% during the fourth quarter. Procyon Advisors LLC now owns 17,025 shares of the company’s stock worth $3,499,000 after purchasing an additional 7,499 shares in the last quarter. Public Sector Pension Investment Board boosted its position in Cardinal Health by 66.7% during the third quarter. Public Sector Pension Investment Board now owns 30,007 shares of the company’s stock worth $4,710,000 after purchasing an additional 12,003 shares in the last quarter. Sierra Summit Advisors LLC acquired a new position in shares of Cardinal Health in the third quarter worth $9,897,000. Finally, Kornitzer Capital Management Inc. KS raised its holdings in shares of Cardinal Health by 100.8% in the fourth quarter. Kornitzer Capital Management Inc. KS now owns 18,164 shares of the company’s stock worth $3,733,000 after acquiring an additional 9,120 shares during the last quarter. 87.17% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Ratings Changes
A number of research firms have recently weighed in on CAH. Citigroup cut their price target on Cardinal Health from $249.00 to $245.00 and set a “buy” rating for the company in a report on Friday, May 1st. JPMorgan Chase & Co. cut their price target on Cardinal Health from $243.00 to $215.00 and set a “neutral” rating for the company in a report on Monday, May 4th. Robert W. Baird set a $248.00 price target on Cardinal Health in a report on Friday, May 1st. Barclays boosted their price target on Cardinal Health from $243.00 to $258.00 and gave the stock an “overweight” rating in a report on Tuesday, February 24th. Finally, Leerink Partners reissued an “outperform” rating and issued a $275.00 price target on shares of Cardinal Health in a report on Monday, March 9th. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat.com, Cardinal Health has an average rating of “Moderate Buy” and a consensus target price of $246.93.
Cardinal Health Trading Up 1.2%
NYSE CAH opened at $223.76 on Friday. The business’s 50-day moving average price is $203.21 and its 200 day moving average price is $208.85. Cardinal Health, Inc. has a twelve month low of $137.75 and a twelve month high of $233.60. The company has a market capitalization of $52.41 billion, a PE ratio of 34.21, a price-to-earnings-growth ratio of 1.21 and a beta of 0.52.
Cardinal Health (NYSE:CAH – Get Free Report) last released its earnings results on Thursday, April 30th. The company reported $3.17 earnings per share for the quarter, topping the consensus estimate of $2.79 by $0.38. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The firm had revenue of $60.94 billion for the quarter, compared to the consensus estimate of $62.10 billion. During the same period in the prior year, the business posted $2.35 earnings per share. The firm’s revenue for the quarter was up 11.0% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. Equities analysts predict that Cardinal Health, Inc. will post 10.76 EPS for the current year.
Cardinal Health Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st will be given a dividend of $0.5158 per share. This represents a $2.06 annualized dividend and a yield of 0.9%. This is a boost from Cardinal Health’s previous quarterly dividend of $0.51. The ex-dividend date is Wednesday, July 1st. Cardinal Health’s dividend payout ratio (DPR) is currently 31.19%.
Cardinal Health Company Profile
Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.
The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.
Featured Stories
- Five stocks we like better than Cardinal Health
- TJX: Retail’s Apex Predator Feasts on Inflation
- MarketBeat Week in Review – 06/08 – 06/12
- SpaceX Rings the Bell and Shatters Every Record
- Adobe Stock Just Got Cheaper—Is Wall Street Missing the Story?
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.
